SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Singh, S
Right arrow Articles by Jindal, S K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S
Right arrow Articles by Jindal, S K
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Aggressive atropinisation and continuous pralidoxime (2-PAM) infusion in patients with severe organophosphate poisoning: experience of a northwest Indian hospital

S Singh

Department of Internal Medicine, Nehru Hospital, 4th Floor, F Block, Room 16, Postgraduate Institute of Medical Education and Research, Chandigarh-160012, India

D Chaudhry

D Behera

D Gupta

S K Jindal

Department of Pulmonary and Critical Care Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh-160012, India

OBJECTIVE: The aim of the study was to find whether continuous pralidoxime (2-PAM) infusion along with aggressive atropinisation improves the outcome in patients with severe organophosphate poisoning who require assisted ventilation.

METHODS: Sixteen patients admitted to the respiratory intensive care unit (RICU) with severe organophosphate poisoning and requiring assisted ventilation were included in the study. The compounds involved were phorate (six), dichlorvos (four), oxydimeton methyl (one), monocrotophos (one), methyl parathion (one) and in three it was unknown. After decontamination, they were given intravenous (iv) bolus atropine 5 mg at onset and then 2.5 mg every 5-10 min till atropinisation was achieved, and then maintained either by intermittent bolus doses or by continuous infusion if the required dose was large. They were also given continuous iv infusion of 2-PAM in dose of 7.5 mg/kg body weight/h (maximum 500 mg/h) after an initial bolus dose of 2 g.

RESULTS: The mean (± S.D.) dose of atropine was 735.02 ± 742.98 mg (range 85-3000 mg) with maximum dose on day 1. The mean (± S.D) duration of2-PAM infusion was 96.4±49.4 h (range 10-216 h). The mean (±S.D) duration of mechanical ventilation (MV) was 131.5 ± 95.65 h (range 4-336 h). Fourteen patients could be successfully extubated and two died of bronchopneumonia and sepsis (mortality 12.5%6).

CONCLUSION: Continuous 2-PAM infusion along with aggressive atropinisation after initial decontamination improved the outcome but notthe duration of MV in severely intoxicated patients with organophosphate compounds who required assisted ventilation in this case series.

Key Words: organophos phatepoisoning • pralidoxime infusion • atropine • outcome

Human & Experimental Toxicology, Vol. 20, No. 1, 15-18 (2001)
DOI: 10.1191/096032701671437581


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
R. Rahimi, S. Nikfar, and M. Abdollahi
Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials
Human and Experimental Toxicology, March 1, 2006; 25(3): 157 - 162.
[Abstract] [PDF]


Home page
J Intensive Care MedHome page
S. W. Wiener and R. S. Hoffman
Nerve Agents: A Comprehensive Review
J Intensive Care Med, January 1, 2004; 19(1): 22 - 37.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. O. Martin and H. P. Adams Jr
Neurological Aspects of Biological and Chemical Terrorism: A Review for Neurologists
Arch Neurol, January 1, 2003; 60(1): 21 - 25.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Eddleston, L. Szinicz, P. Eyer, and N. Buckley
Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials
QJM, May 1, 2002; 95(5): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
A M Tsatsakis, G K Bertsias, V Liakou, I N Mammas, I Stiakakis, and G N Tzanakakis
Severe fenthion intoxications due to ingestion and inhalation with survival outcome
Human and Experimental Toxicology, January 1, 2002; 21(1): 49 - 54.
[Abstract] [PDF]



Advertisement